Ten patients refused the proposed treatment; 3 patients died of non-oncological causes during the duration of the study; and 12 patients were excluded due to severe renal failure, elevated creatinine levels, and low GFR, which could affect the results of the HE4 marker. Here, WFDC2 is linked to acute kidney injury.